KA
PODD icon

Kozak & Associates’s Insulet PODD Stock Holding History

Kozak & Associates’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3K Hold
108
– – ﹤0.01% 217
2026
Q1 		$21.4K Hold
108
– – ﹤0.01% 197
2025
Q4 		$31.2K Hold
108
– – 0.01% 172
2025
Q3 		$35.4K Hold
108
– – 0.01% 160
2025
Q2 		$32.1K Buy
+108
New +$31.2K 0.01% 172

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kozak & Associates's PODD Position: Q2 2026 in Review

Kozak & Associates held its Insulet (PODD) position steady in Q2 2026 at 108 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #217.

Kozak & Associates first reported a position in PODD in Q2 2025 and has held it in 5 quarters since. The position peaked at $35.4K in Q3 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Kozak & Associates held 108 shares of Insulet worth $17.3K as of Q2 2026.
  • Kozak & Associates left its Insulet share count unchanged in Q2 2026.
  • Insulet made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #217 holding.
  • Kozak & Associates first reported a position in Insulet in Q2 2025 and has held it in 5 quarters since.
  • Kozak & Associates's Insulet position peaked at $35.4K in Q3 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.